◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › A › APCO

Asian Phytoceuticals Public Company Limited (APCO) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Consumer Defensive · Household & Personal Products · DATA UPDATED 2026-08-22

Asian Phytoceuticals Public Company Limited (APCO) operates in the Household & Personal Products industry and is headquartered in Lamphun, Thailand. Its market capitalization is roughly THB 2 billion. In the fiscal year ended 2025-12-31, APCO reported THB 200M in revenue and THB 55M in net income.

Asian Phytoceuticals Public Company Limited engages in the research and development, manufacture, and distribution of healthcare and natural extracts-based beauty products in Thailand.

Interactive charts & full statements →

APCO Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	THB 200M	THB 211M	THB 293M	THB 250M	—
Gross Profit	THB 169M	THB 170M	THB 236M	THB 202M	—
Operating Income (EBIT)	THB 56M	THB 53M	THB 117M	THB 88M	—
Net Income	THB 55M	THB 55M	THB 108M	THB 81M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

APCO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total Revenue	THB 50M	THB 52M	THB 50M	THB 49M	THB 48M	—
Gross Profit	THB 42M	THB 44M	THB 42M	THB 42M	THB 40M	—
Operating Income (EBIT)	THB 14M	THB 18M	THB 15M	THB 12M	THB 11M	—
Net Income	THB 18M	THB 15M	THB 15M	THB 13M	THB 12M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

APCO Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(THB 55M)	(THB 108M)	(THB 93M)	(THB 74M)	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

APCO Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	THB 0M	THB 0M	THB 0M	(THB 55M)	THB 0M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

APCO Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	THB 628M	THB 636M	THB 705M	THB 680M	—
Total Liabilities	THB 68M	THB 76M	THB 92M	THB 70M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive APCO viewer.

Other Companies in Household & Personal Products

KISS · Rojukiss International Public Company Limited — THB 2 billion
4918 · Ivy Cosmetics Corporation — JPY 2 billion
TNR · Thai Nippon Rubber Industry Public Co., Ltd. — THB 2 billion
0837 · Carpenter Tan Holdings Limited — HK$2 billion
EPC · Edgewell Personal Care Company — $1 billion
5341 · Asahi Eito Holdings Co.,Ltd. — JPY 1 billion
2569 · Soft International Group Ltd. — HK$1 billion
JCT · Jack Chia Industries (Thailand) Public Company Limited — THB 1 billion

← APCB All “A” companies APCS →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.